mrna-based sars-cov-2 vaccines are highly effective among dialysis patients. this study found no difference effectiveness mrna-based covid-19 vaccine bnt162b2 &amp; adenovirus vaccine vectorâ€“based ad.cov2.s over first 6 months postvaccination